Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.ayurvedganga.com | |
Market Cap | 5.66 Cr. | |
Enterprise Value(EV) | 7.56 Cr. | 2022-03 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 0.09 | Trailing Twelve Months Ending 2022-03 |
Price-Earning Ratio (PE) | 152.91 | Trailing Twelve Months Ending 2022-03 |
Industry PE | 31.71 | Trailing Twelve Months Ending 2022-03 |
Book Value / Share | 13.32 | Trailing Twelve Months Ending 2022-03 |
Price to Book Value | 1.05 | Calculated using Price: 13.93 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 0.41 Cr. | 4,061,500 Shares |
FaceValue | 10 | |
Company Profile | ||
The company is a producer of quality bulk ayurvedic medicines in Mumbai. Apart from manufacturing, the company is also into marketing, distribution of Bulk Ayurvedic Medicines. Its product includes Ampachan Vati; Khadira Vati; Nirmalaya churna etc. Its products are available in liquid dosage form and solid dosage forms. |
1 Day |
|
|
1 Week |
|
-9.91% |
1 Month |
|
-9.91% |
3 Month |
|
+29.38% |
6 Month |
|
+29.38% |
1 Year |
|
+22.44% |
2 Year |
|
+67.33% |
5 Year |
|
+86.48% |
10 Year |
|
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 1.16 | 1.28 | 1.36 | 1.57 | 1.91 | 3.70 | 3.59 | 0.38 | 0.70 | |
Return on Capital Employed (%) | 7.68 | 8.03 | 6.88 | 6.15 | 5.83 | 7.26 | 7.18 | 3.36 | 3.41 | |
Return on Assets (%) | 0.61 | 0.64 | 0.77 | 0.99 | 1.19 | 2.34 | 2.46 | 0.27 | 0.48 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Shh. Funds | 3 | 3 | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | |
Non Curr. Liab. | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Curr. Liab. | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | |
Minority Int. | |||||||||||
Equity & Liab. | 5 | 5 | 5 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | |
Non Curr. Assets | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | |
Curr. Assets | 2 | 2 | 2 | 5 | 4 | 5 | 4 | 4 | 5 | 5 | |
Misc. Exp. not W/O | 0 | ||||||||||
Total Assets | 5 | 5 | 5 | 7 | 8 | 8 | 8 | 8 | 8 | 8 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Net Sales | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 2 | |
Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Income | 2 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | |
Total Expenditure | -2 | -2 | -2 | -2 | -3 | -3 | -3 | -3 | -2 | -2 | |
PBIDT | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 0 | |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Taxation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Exceptional Items | |||||||||||
PAT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Adjusted EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 | |
Cash Fr. Inv. | 0 | 0 | 0 | -1 | 1 | 0 | 0 | 0 | 0 | 0 | |
Cash Fr. Finan. | 0 | 0 | 0 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | |
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Fri, 13 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depositories andParticipants) Regulations 2018 for the quarter ended December 31 2022. |
Thu, 12 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022. |
Fri, 11 Nov 2022
Board Meeting Outcome for Outcome Of Board Meeting Held On Friday November 11 2022 Considered and Approved the un- audited Financial Results of the Company for the half year ended on September 30 2022 |
No Scans Found |